Simulations Plus to Attend Investor Conferences in Boston and New York City
PorAinvest
miércoles, 27 de agosto de 2025, 6:15 pm ET1 min de lectura
SLP--
Simulations Plus provides advanced software and consulting services to the biopharma industry, focusing on drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company's solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Their technology is utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide [1].
The participation of O'Connor in these high-profile conferences provides an opportunity for investors to gain insights into Simulations Plus's strategies, market position, and future prospects. Interested parties can access the webcast links on the scheduled dates and times to follow these events.
References:
[1] https://www.stocktitan.net/news/SLP/simulations-plus-to-participate-in-upcoming-investor-uom4jckq1imi.html
[2] https://www.stocktitan.net/news/LLY/lilly-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-ngk18zw3oh9e.html
Simulations Plus CEO Shawn O'Connor will attend the 2025 Wells Fargo Healthcare Conference in Boston and the Morgan Stanley 23rd Annual Global Healthcare Conference in New York City. The events will feature fireside chats and one-on-one meetings, and interested parties can access webcast links on the scheduled dates and times. Simulations Plus provides cheminformatics, biosimulation, and simulation-enabled performance solutions to the biopharma industry, integrating AI/ML technologies and various modeling approaches.
Simulations Plus, Inc. (SLP) has announced that Shawn O'Connor, Chief Executive Officer, will participate in two significant investor events in September. The first event is the 2025 Wells Fargo Healthcare Conference in Boston, where O'Connor will engage in a fireside chat and one-on-one meetings on Wednesday and Thursday, September 3-4, 2025. The webcast link for the event is available here [1]. The second event is the Morgan Stanley 23rd Annual Global Healthcare Conference in New York City, scheduled for Wednesday, September 10, 2025. O'Connor will also participate in a fireside chat and one-on-one meetings at this event. The webcast link for this event can be found here [2].Simulations Plus provides advanced software and consulting services to the biopharma industry, focusing on drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company's solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Their technology is utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide [1].
The participation of O'Connor in these high-profile conferences provides an opportunity for investors to gain insights into Simulations Plus's strategies, market position, and future prospects. Interested parties can access the webcast links on the scheduled dates and times to follow these events.
References:
[1] https://www.stocktitan.net/news/SLP/simulations-plus-to-participate-in-upcoming-investor-uom4jckq1imi.html
[2] https://www.stocktitan.net/news/LLY/lilly-to-participate-in-morgan-stanley-23rd-annual-global-healthcare-ngk18zw3oh9e.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios